Is a complete HIMS research report available?

No complete published report is available for Hims & Hers Health, Inc. (HIMS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Hims & Hers Health, Inc. (HIMS)

NYSE: HIMS · USD

$29.4

+1.45 (+5.2%)· Recorded snapshot

Market cap	6.9B
Revenue (ttm)	2.6B
Net income (ttm)	-142M
EPS (ttm)	-$0.62
Shares out	233.3M
P/E (forward)	84.9x
Volume	11,206,289
Beta	2.43

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6B
Net income (ttm): -142M
EPS (ttm): -$0.62
P/E (forward): 84.9x
Market cap: 6.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001773751
Company name	Hims & Hers Health, Inc.
Country	United States
Country code	US
CUSIP number	433000106
Earnings date	2026-11-09
Earnings time	amc
Employees	2,442
Employees change	805
Employees growth	49.18%
Enterprise value	$7.6B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US4330001060
Last 10-K release date	2026-02-23
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$6.9B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$29.37
Price currency	USD
Sector	Healthcare
SIC code	8011
Stock price date	2026-10-28
Symbol	HIMS
U.S. state	California
Website	https://www.hims.com

Metric

Value

Amount currency

USD

CIK code

0001773751

Company name

Hims & Hers Health, Inc.

Country

United States

Country code

CUSIP number

433000106

Earnings date

2026-11-09

Earnings time

amc

Employees

2,442

Employees change

805

Employees growth

49.18%

Enterprise value

$7.6B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

In index

RUSSELL2000

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

Is SPAC

ISIN number

US4330001060

Last 10-K release date

2026-02-23

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$6.9B

Market cap category

Mid-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$29.37

Price currency

USD

Sector

Healthcare

SIC code

8011

Stock price date

2026-10-28

Symbol

HIMS

U.S. state

California

Website

https://www.hims.com

Metric	Value
Adjusted P/E ratio	130.24x
Earnings yield	-2.12%
EV/FCF	91.81x
EV/Sales	2.96x
FCF / EV yield	1.09%
FCF yield	1.2%
Forward EV/Sales	2.07x
Forward P/E	84.92x
Forward P/S	1.88x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/(OCF - SBC) ratio	63x
P/B ratio	20.1x
P/FCF ratio	83.32x
P/OCF ratio	26.26x
P/S ratio	2.68x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

130.24x

Earnings yield

-2.12%

EV/FCF

91.81x

EV/Sales

2.96x

FCF / EV yield

1.09%

FCF yield

1.2%

Forward EV/Sales

2.07x

Forward P/E

84.92x

Forward P/S

1.88x

Industry forward P/E

13.86x

Industry P/E

173.47x

P/(OCF - SBC) ratio

63x

P/B ratio

20.1x

P/FCF ratio

83.32x

P/OCF ratio

26.26x

P/S ratio

2.68x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-3.78%
EBITDA margin	-0.39%
FCF margin	3.22%
Gross margin	69.53%
Operating margin	-3.78%
Pretax margin	-6.35%
Profit margin	-5.51%
Profit per employee	$-58,161
Profitable years	2
Revenue per employee	$1.1M
ROA	-2.21%
ROA (5Y)	-5.39%
ROCE	-4.54%
ROE	-32.03%
ROE (5Y)	-4.15%
ROIC	-10.49%
SBC / revenue	5.96%
Tax / revenue	-0.84%

Metric

Value

EBIT margin

-3.78%

EBITDA margin

-0.39%

FCF margin

3.22%

Gross margin

69.53%

Operating margin

-3.78%

Pretax margin

-6.35%

Profit margin

-5.51%

Profit per employee

$-58,161

Profitable years

Revenue per employee

$1.1M

ROA

-2.21%

ROA (5Y)

-5.39%

ROCE

-4.54%

ROE

-32.03%

ROE (5Y)

-4.15%

ROIC

-10.49%

SBC / revenue

5.96%

Tax / revenue

-0.84%

Metric	Value
EPS growth years	0
FCF growth	-37.28%
FCF growth 3Y	67.01%
Gross profit growth	16.83%
Gross profit growth (Q)	15.52%
Gross profit growth 3Y	46.48%
Gross profit growth 5Y	64.09%
Net income growth years	4
OCF growth	0.7%
OCF growth 3Y	117.58%
Revenue growth	28.04%
Revenue growth (Q)	38.25%
Revenue growth (QoQ)	23.86%
Revenue growth 3Y	53.65%
Revenue growth 5Y	67.46%
Revenue growth quarters	23
Revenue growth years	6

Metric

Value

EPS growth years

FCF growth

-37.28%

FCF growth 3Y

67.01%

Gross profit growth

16.83%

Gross profit growth (Q)

15.52%

Gross profit growth 3Y

46.48%

Gross profit growth 5Y

64.09%

Net income growth years

OCF growth

0.7%

OCF growth 3Y

117.58%

Revenue growth

28.04%

Revenue growth (Q)

38.25%

Revenue growth (QoQ)

23.86%

Revenue growth 3Y

53.65%

Revenue growth 5Y

67.46%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-180.4M
Depreciation and amortization	$87.2M
EBIT	$-97.4M
EBITDA	$-10.2M
EPS	$-0.62
FCF per share	$0.36
Financing cash flow	$127.3M
Free cash flow	$83M
Free cash flow minus SBC	$-70.6M
Gross profit	$1.8B
Income taxes	$-21.6M
Investing cash flow	$-902M
Net borrowing	$390.4M
Net cash flow	$-515.1M
Net income	$-142M
Operating cash flow minus SBC	$109.8M
Operating income	$-97.4M
Revenue	$2.6B
Stock-based compensation	$153.6M

Metric

Value

Capital expenditures

$-180.4M

Depreciation and amortization

$87.2M

EBIT

$-97.4M

EBITDA

$-10.2M

EPS

$-0.62

FCF per share

$0.36

Financing cash flow

$127.3M

Free cash flow

$83M

Free cash flow minus SBC

$-70.6M

Gross profit

$1.8B

Income taxes

$-21.6M

Investing cash flow

$-902M

Net borrowing

$390.4M

Net cash flow

$-515.1M

Net income

$-142M

Operating cash flow minus SBC

$109.8M

Operating income

$-97.4M

Revenue

$2.6B

Stock-based compensation

$153.6M

Metric	Value
Altman Z-Score	1.98
Book value per share	$1.39
Debt / EBITDA	171.37
Debt / equity	4.77
Debt / FCF	18.62
Goodwill	$1.1B
Interest coverage	-10.44
Long-term assets	$2.2B
Long-term liabilities	$1.8B
Net cash (debt)	$-705.2M
Net cash / market cap	-10.19%
Net debt / equity	2.18
Net debt / FCF	8.49
Piotroski F-Score	2
Property, plant and equipment	$529.8M
Shareholders' equity	$324.1M
Tangible book value	$-1.2B
Tangible book value per share	$-5.15
Total assets	$3.6B
Total cash	$841M
Total debt	$1.5B
Total liabilities	$3.3B
WACC	14.49%

Metric

Value

Altman Z-Score

1.98

Book value per share

$1.39

Debt / EBITDA

171.37

Debt / equity

4.77

Debt / FCF

18.62

Goodwill

$1.1B

Interest coverage

-10.44

Long-term assets

$2.2B

Long-term liabilities

$1.8B

Net cash (debt)

$-705.2M

Net cash / market cap

-10.19%

Net debt / equity

2.18

Net debt / FCF

8.49

Piotroski F-Score

Property, plant and equipment

$529.8M

Shareholders' equity

$324.1M

Tangible book value

$-1.2B

Tangible book value per share

$-5.15

Total assets

$3.6B

Total cash

$841M

Total debt

$1.5B

Total liabilities

$3.3B

WACC

14.49%

Metric	Value
Asset turnover	0.94
Current assets	$1.4B
Current liabilities	$1.5B
Current ratio	0.93
Inventory turnover	6.84
Net working capital	$-928.1M
Quick ratio	0.82
Working capital	$-98.6M
Working capital turnover	5.24

Metric

Value

Asset turnover

0.94

Current assets

$1.4B

Current liabilities

$1.5B

Current ratio

0.93

Inventory turnover

6.84

Net working capital

$-928.1M

Quick ratio

0.82

Working capital

$-98.6M

Working capital turnover

5.24

Metric	Value
Buyback yield / dilution	7.33%
Dividend yield	0%
Shareholder yield	7.33%

Metric

Value

Buyback yield / dilution

7.33%

Dividend yield

Shareholder yield

7.33%

Metric	Value
150-day SMA	$28.59
1D price change	5.19%
1M price change	-0.17%
1M total return	-0.17%
1W price change	0.55%
1W total return	0.55%
1Y price change	-39.1%
1Y return CAGR	-39.12%
1Y total return	-39.1%
20-day SMA	$28.99
200-day SMA	$27.06
3M price change	-2.88%
3M total return	-2.88%
3Y price change	408.13%
3Y return CAGR	71.9%
3Y total return	408.13%
50-day SMA	$29.15
50-day SMA vs 200-day SMA	50over200
52-week high	$49.17
52-week high date	2025-10-28
52-week low	$13.74
52-week low date	2026-02-24
5Y price change	294.76%
5Y return CAGR	31.61%
5Y total return	294.76%
6M price change	-0.07%
6M total return	-0.07%
All-time high	$72.98
All-time high date	2025-02-19
All-time low	$2.72
All-time low date	2022-05-12
Average true range (ATR)	$1.72
Average volume	9.7M
Beta (1Y)	2.74
Beta (2Y)	2.5
Beta (5Y)	2.43
Change from 52-week high	-40.27%
Change from 52-week low	113.76%
Change from all-time high	-59.76%
Change from all-time low	979.78%
Change from open	5.99%
Day's gap	-0.75%
Dollar volume	$329.1M
High price	$29.80
Low price	$27.70
Monthly RSI	49.78
Open price	$27.71
Position in 52-week range	79.52%
Premarket change	-0.18%
Premarket close	$27.92
Premarket price	$27.87
Premarket volume	79.7K
Previous close	$27.92
Price vs 150-day SMA	2.74%
Price vs 20-day SMA	1.31%
Price vs 200-day SMA	8.53%
Price vs 50-day SMA	0.75%
Relative volume	1.17
RSI	52.24
Sharpe ratio	-0.18
Sharpe ratio (3Y)	0.98
Sharpe ratio (5Y)	0.67
Sortino ratio	-0.21
Sortino ratio (3Y)	1.6
Sortino ratio (5Y)	1.12
Volume	11.2M
Weekly RSI	50.47
YTD price change	-9.55%
YTD total return	-9.55%

Metric

Value

150-day SMA

$28.59

1D price change

5.19%

1M price change

-0.17%

1M total return

-0.17%

1W price change

0.55%

1W total return

0.55%

1Y price change

-39.1%

1Y return CAGR

-39.12%

1Y total return

-39.1%

20-day SMA

$28.99

200-day SMA

$27.06

3M price change

-2.88%

3M total return

-2.88%

3Y price change

408.13%

3Y return CAGR

71.9%

3Y total return

408.13%

50-day SMA

$29.15

50-day SMA vs 200-day SMA

50over200

52-week high

$49.17

52-week high date

2025-10-28

52-week low

$13.74

52-week low date

2026-02-24

5Y price change

294.76%

5Y return CAGR

31.61%

5Y total return

294.76%

6M price change

-0.07%

6M total return

-0.07%

All-time high

$72.98

All-time high date

2025-02-19

All-time low

$2.72

All-time low date

2022-05-12

Average true range (ATR)

$1.72

Average volume

9.7M

Beta (1Y)

2.74

Beta (2Y)

2.5

Beta (5Y)

2.43

Change from 52-week high

-40.27%

Change from 52-week low

113.76%

Change from all-time high

-59.76%

Change from all-time low

979.78%

Change from open

5.99%

Day's gap

-0.75%

Dollar volume

$329.1M

High price

$29.80

Low price

$27.70

Monthly RSI

49.78

Open price

$27.71

Position in 52-week range

79.52%

Premarket change

-0.18%

Premarket close

$27.92

Premarket price

$27.87

Premarket volume

79.7K

Previous close

$27.92

Price vs 150-day SMA

2.74%

Price vs 20-day SMA

1.31%

Price vs 200-day SMA

8.53%

Price vs 50-day SMA

0.75%

Relative volume

1.17

RSI

52.24

Sharpe ratio

-0.18

Sharpe ratio (3Y)

0.98

Sharpe ratio (5Y)

0.67

Sortino ratio

-0.21

Sortino ratio (3Y)

1.6

Sortino ratio (5Y)

1.12

Volume

11.2M

Weekly RSI

50.47

YTD price change

-9.55%

YTD total return

-9.55%

Metric	Value
Float	213.8M
Float percentage	91.62%
Shares change (QoQ)	1.48%
Shares change (YoY)	-7.33%
Shares held by insiders	8.36%
Shares held by institutions	66.7%
Shares outstanding	233.3M
Short % of float	25.62%
Short % of shares	23.47%
Short ratio	5.8 days

Metric

Value

Float

213.8M

Float percentage

91.62%

Shares change (QoQ)

1.48%

Shares change (YoY)

-7.33%

Shares held by insiders

8.36%

Shares held by institutions

66.7%

Shares outstanding

233.3M

Short % of float

25.62%

Short % of shares

23.47%

Short ratio

5.8 days

Metric	Value
Page views	190

Metric

Value

Page views

190

Hims & Hers Health, Inc. (HIMS)

Price

Financial snapshot

Fair-value bridge

Latest news · HIMS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HIMS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on HIMS

Frequently asked questions